Subscribe
Sign in
Home
Podcast
The Book
FemmeHealth Alliance
Signal Not Noise
About
Latest
Top
Discussions
Why Women's Health Is the First Test of Precision Health
Women's health is one of the clearest tests of precision healthcare. Discover why biological time is reshaping medicine, innovation and healthcare…
Jun 28
•
Maryann
11
4
The Work Behind This Newsletter and What Comes Next.
For the last three years, I have written The Billion Dollar Blindspot largely because I could not stop thinking about the same question:
Jun 25
•
Maryann
8
4
The Women’s Health Capital Thesis: Why Precision Health Is Becoming an Institutional Investment Opportunity
How sex-specific medicine, emerging healthcare LP demand, the Great Wealth Transfer, and specialist-manager access are reshaping women’s health…
Jun 22
•
Maryann
11
5
When Care Becomes Leverage: Who Owns Women’s Health Infrastructure?
Women’s health needs more capital. But as clinics consolidate, the more urgent question is whether ownership models protect continuity of care, clinical…
Jun 21
•
Maryann
28
5
9
Being Diagnosed Isn't the Same as Being Studied
Women with ADHD are being treated with medications whose pivotal trials never tracked menstrual cycle phase, hormonal variability, or perimenopausal…
Jun 14
•
Maryann
24
6
Was ADHD Built for Boys? Why Thousands of Women Are Being Diagnosed Decades Later
Why are so many women being diagnosed with ADHD in their 40s and 50s? This article explores the history of ADHD research, the possibility of diagnostic…
Jun 7
•
Maryann
43
18
6
May 2026
Women Now Spend a Third of Their Lives After Menopause. Medicine Hasn't Caught Up.
For decades, medicine treated estrogen primarily as a reproductive hormone. New evidence suggests we may have misunderstood what it was doing all along.
May 31
•
Maryann
47
5
10
Why Women’s Health Became a Billion-Dollar Blind Spot in Capital Markets
Why women’s health remained overlooked for decades, how incomplete data created market blind spots and why investors are finally paying attention.
May 24
•
Maryann
53
22
16
The Billion Dollar Blind Spot Began in a Doctor’s Office
The story behind The Billion Dollar Blind Spot and the structural forces reshaping healthcare innovation and capital allocation.
May 17
•
Maryann
15
2
4
The Wealth-Health Convergence
Why the largest intergenerational wealth transfer in history may become the catalyst for a structural repricing in women’s health investing.
May 16
•
Maryann
21
2
7
UCB Just Paid $2.2 Billion for an Autoimmune Platform. The Indication List Tells You More Than the Deal Price.
UCB’s acquisition of Candid Therapeutics is being framed as a next-generation immunology platform deal. But beneath the immune-reset narrative lies a…
May 12
•
Maryann
17
4
4
The Future of Medicine Is Being Built on Incomplete Biology
A new Nature Neuroscience commentary warns that phasing out animal research before female biology is well understood could lock historical male bias…
May 9
•
Maryann
32
4
9
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
